相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Antidiabetic drug pioglitazone protects the heart via activation of PPAR-γ receptors, PI3-kinase, Akt, and eNOS pathway in a rabbit model of myocardial infarction
Shinji Yasuda et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2009)
GLP-1R Agonist Liraglutide Activates Cytoprotective Pathways and Improves Outcomes After Experimental Myocardial Infarction in Mice
Mohammad Hossein Noyan-Ashraf et al.
DIABETES (2009)
Dipeptidyl Peptidase-IV Inhibitor Use Associated With Increased Risk of ACE Inhibitor-Associated Angioedema
Nancy J. Brown et al.
HYPERTENSION (2009)
Exenatide Reduces Infarct Size and Improves Cardiac Function in a Porcine Model of Ischemia and Reperfusion Injury
Leo Timmers et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials A Position Statement of the American Diabetes Association and a Scientific Statement of the American College of Cardiology Foundation and the American Heart Association
Jay S. Skyler et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
The cardioprotective and inotropic components of the postconditioning effects of GLP-1 and GLP-1(9-36)a in an isolated rat heart
Alvilde Ossum et al.
PHARMACOLOGICAL RESEARCH (2009)
The role of eNOS, iNOS, and NF-κB in upregulation and activation of cyclooxygenase-2 and infarct size reduction by atorvastatin
Yumei Ye et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2008)
Pioglitazone protects the myocardium against ischemia-reperfusion injury in eNOS and iNOS knockout mice
Yumei Ye et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2008)
CREB activation and ischaemic preconditioning
E. Marais et al.
CARDIOVASCULAR DRUGS AND THERAPY (2008)
PDE4 inhibitor, roflumilast protects cardiomyocytes against NO-induced apoptosis via activation of PKA and Epac dual pathways
Hyun-Jeong Kwak et al.
CELLULAR SIGNALLING (2008)
Hyperglycemia and acute coronary syndrome - A scientific statement from the American heart association diabetes committee of the council on nutrition, physical activity, and metabolism
Prakash Deedwania et al.
CIRCULATION (2008)
Cardioprotective and vasodilatory actions of glucagon-like peptide 1 receptor are mediated through both glucagon-like peptide 1 receptor-dependent and -independent pathways
Kiwon Ban et al.
CIRCULATION (2008)
National Cholesterol Education Program and International Diabetes Federation Definitions of metabolic syndrome in the prediction of diabetes. Results from the Flrenze-Bagno - A Ripoli study
E. Mannucci et al.
DIABETES OBESITY & METABOLISM (2008)
Protein kinase D links Gq-coupled receptors to cAMP response element-binding protein (CREB)-Ser133 phosphorylation in the heart
Nazira Ozgen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Phosphorylation of 5-lipoxygenase at Ser(523) by protein kinase a determines whether pioglitazone and atorvastatin induce proinflammatory leukotriene B-4 or anti-inflammatory 15-epi-lipoxin A(4) production
Yumei Ye et al.
JOURNAL OF IMMUNOLOGY (2008)
Protective effects of GLP-1 analogues exendin-4 and GLP-1(9-36) amide against ischemia-reperfusion injury in rat heart
David P. Sonne et al.
REGULATORY PEPTIDES (2008)
The cardioprotective effect of a statin and cilostazol combination: Relationship to akt and endothelial nitric oxide synthase activation
Saraswathy Manickavasagam et al.
CARDIOVASCULAR DRUGS AND THERAPY (2007)
Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus - A meta-analysis of randomized trials
A. Michael Lincoff et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Myocardial ischaemia-reperfusion injury is attenuated by intact glucagon like peptide-1 (GLP-1) in the in vitro rat heart and may involve the p70s6K pathway
Amal K. Bose et al.
CARDIOVASCULAR DRUGS AND THERAPY (2007)
Activation of peroxisome proliferator-activated receptor-γ (PPAR-γ) by atorvastatin is mediated by 15-deoxy-delta-12,14-PGJ2
Yumei Ye et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2007)
Mediating δ-opioid-initiated heart protection via the β2-adrenergic receptor:: role of the intrinsic cardiac adrenergic cell
Ming-He Huang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2007)
Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes
Steven E. Nissen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
被撤回的出版物: Ischemic preconditioning involves dual cardio-protective axes with p38MAPK as upstream target (Retracted article. See vol. 53, pg. 743, 2012)
Norbert Nagy et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2007)
Effect of pioglitazone compared with glimepiride on carotid intima-media thickness in type 2 diabetes - A randomized trial
Theodore Mazzone et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes
Daniel J. Drucker et al.
LANCET (2006)
Signaling pathways regulating murine cardiac CREB phosphorylation
Bailing Li et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Cardioprotective effects of acute and chronic opioid treatment are mediated via different signaling pathways
Jason N. Peart et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2006)
Myocardial protection by pioglitazone, atorvastatin, and their combination: mechanisms and possible interactions
Yumei Ye et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2006)
Augmentation of myocardial production of 15-epi-lipoxin-A4 by pioglitazone and atorvastatin in the rat
Yochai Birnbaum et al.
CIRCULATION (2006)
Cardioprotective effects of rosiglitazone are associated with selective overexpression of type 2 angiotensin receptors and inhibition of p42/44 MAPK
Behzad Molavi et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2006)
Survival kinases in ischemic preconditioning and postconditioning
Derek J. Hausenloy et al.
CARDIOVASCULAR RESEARCH (2006)
Pioglitazone mimics preconditioning in the isolated perfused rat heart - A role for the prosurvival kinases PI3K and P42/44MAPK
AM Wynne et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2005)
Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events):: a randomised controlled trial
JA Dormandy et al.
LANCET (2005)
Resveratrol-mediated activation of cAMP response element-binding protein through adenosine A3 receptor by Akt-dependent and -independent pathways
S Das et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Failure to protect the myocardium against ischemia/reperfusion injury after chronic atorvastatin treatment is recaptured by acute atorvastatin treatment - A potential role for phosphatase and tensin homolog deleted on chromosome ten?
K Mensah et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Glucagon-like peptide 1 can directly protect the heart against ischemia/reperfusion injury
AK Bose et al.
DIABETES (2005)
Glucagon like peptide-1 is protective against myocardial ischemia/reperfusion injury when given either as a preconditioning mimetic or at reperfusion in an isolated rat heart model
AK Bose et al.
CARDIOVASCULAR DRUGS AND THERAPY (2005)
Pharmacological preconditioning with resveratrol: role of CREB-dependent Bcl-2 signaling via adenosine A(3) receptor activation
S Das et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2005)
Ischemic preconditioning attenuates calpain-mediated degradation of structural proteins through a protein kinase A-dependent mechanism
J Inserte et al.
CARDIOVASCULAR RESEARCH (2004)
Acute activation and phosphorylation of endothelial nitric oxide synthase by HMG-CoA reductase inhibitors
MB Harris et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2004)
Protein kinase A as another mediator of ischemic preconditioning independent of protein kinase C
S Sanada et al.
CIRCULATION (2004)
Diazoxide-mediated preconditioning against apoptosis involves activation of cAMP-response element-binding protein (CREB) and NFκB
RA Eliseev et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Effect of acute hyperglycemia on the ischemic preconditioning effect of prodromal angina pectoris in patients with a first anterior wall acute myocardial infarction
M Ishihara et al.
AMERICAN JOURNAL OF CARDIOLOGY (2003)
Shear stress stimulates phosphorylation of eNOS at Ser635 by a protein kinase A-dependent mechanism
YC Boo et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2002)
Shear stress stimulates phosphorylation of endothelial nitric-oxide synthase at Ser1179 by Akt-independent mechanisms -: Role of protein kinase A
YC Boo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Dipeptidyl peptidase IV activity in patients with ACE-inhibitor-associated angioedema
J Lefebvre et al.
HYPERTENSION (2002)
In vivo myocardial protection from ischemia/reperfusion injury by the peroxisome proliferator-activated receptor-γ agonist rosiglitazone
TL Yue et al.
CIRCULATION (2001)
Cardioprotective effect afforded by transient exposure to phosphodiesterase III inhibitors - The role of protein kinase A and p38 mitogen-activated protein kinase
S Sanada et al.
CIRCULATION (2001)
Biphasic response of cardiac NO synthase isoforms to ischemic preconditioning in conscious rabbits
YT Xuan et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2000)
Characterization of G-protein signaling in ventricular myocytes from the adult mouse heart: Differences from the rat
R Hilal-Dandan et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2000)
分享论文
